Sonoma Orthopedic Products, Inc. – Trademark Portfolio
Entity Type: 03
Sonoma Orthopedic Products, Inc. holds 19 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 10 (Medical Apparatus) — 18 filings in this category. The portfolio also extends into Class 41 (Education & Entertainment) across 3 Nice Classification classes. Currently, 2 trademarks are registered. Notable registered marks include WRX and FIBULOCK. The owner is based in Buffalo Grove, IL.
1388 Busch Parkway
Buffalo Grove, IL 60089
Showing of trademarks Trademarks
Trademark Classifications
Sonoma Orthopedic Products, Inc.'s trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Education; providing of training; entertainment; sporting and cultural activities
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Frequently Asked Questions
How many trademarks does Sonoma Orthopedic Products, Inc. have?
Sonoma Orthopedic Products, Inc. has 19 U.S. trademarks filed with the USPTO. Of these, 2 registered, 10 abandoned, 7 cancelled.
What trademark classes does Sonoma Orthopedic Products, Inc. file in?
Sonoma Orthopedic Products, Inc. files trademarks across 3 Nice Classification classes. The most active classes are Class 10 (Medical Apparatus), Class 41 (Education & Entertainment), Class 44 (Medical Services). Class 10 covers surgical, medical, dental and veterinary apparatus and instruments.
What are Sonoma Orthopedic Products, Inc.'s most well-known trademarks?
Sonoma Orthopedic Products, Inc.'s registered trademark portfolio includes well-known marks such as WRX and FIBULOCK. These are among 2 currently registered trademarks in the portfolio.
What is Sonoma Orthopedic Products, Inc.'s trademark registration success rate?
Sonoma Orthopedic Products, Inc. has a 11% trademark registration rate, with 2 out of 19 resolved applications resulting in successful registration. Currently, 0 applications are pending review.